Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19
A. E. Oja, A. Saris, C. A. Ghandour, N. A. M. Kragten, B. M. Hogema, E. J. Nossent, L. M. A. Heunks, S. Cuvalay, E. Slot, F. H. Swaneveld, H. Vrielink, T. Rispens, E. van der Schoot, R. A. W. van Lier, A. Ten Brinke, P. Hombrink
The paper compares T and B cell responses in severe versus mild COVID-19 patients, finding impaired CD4+ T cell responses but strong IgG antibodies in severe cases.
bioRxiv · Jun 18, 2020 · PreprintImmunology